Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+48Malignant Bladder Neoplasm+24Malignant Laryngeal Neoplasm+24Cutaneous Melanoma+20Malignant Esophageal Neoplasm+16Malignant Pancreatic Neoplasm+16Malignant Salivary Gland Neop…+16Malignant Prostate Neoplasm+12Malignant Testicular Neoplasm+12Malignant Mesothelioma+8Malignant Kidney Neoplasm+4Malignant Liver Neoplasm+4Malignant Rectal Neoplasm+4Malignant Anal Neoplasm0Malignant Lung Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+48100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
21187
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
88
activityPercentile
40

ranking row 2607601

2▲3Malignant Bladder Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12460
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
72
activityPercentile
48

ranking row 2607603

2▲2Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3125
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2607602

4▼1Cutaneous Melanoma+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5357
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
44
activityPercentile
24

ranking row 2607604

5▲4Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12697
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2607605

5▲10Malignant Pancreatic Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
25186
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
92
activityPercentile
76

ranking row 2607606

5▲3Malignant Salivary Gland Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
732
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
28
activityPercentile
12

ranking row 2607607

8▲9Malignant Prostate Neoplasm+1272Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
33363
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2607608

8▼1Malignant Testicular Neoplasm+1272Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
510
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
16
activityPercentile
4

ranking row 2607609

10▲2Malignant Mesothelioma+864Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1625
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2607610

11▲5Malignant Kidney Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9519
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
60
activityPercentile
56

ranking row 2607611

11▲11Malignant Liver Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
18884
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
84
activityPercentile
80

ranking row 2607612

11▲3Malignant Rectal Neoplasm+460Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7373
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
56
activityPercentile
52

ranking row 2607613

14▲6Malignant Anal Neoplasm048Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
615
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
20
activityPercentile
20

ranking row 2607616

14▲9Malignant Lung Neoplasm048Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
69357
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2607614

14▲10Malignant Thyroid Gland Neoplasm048Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1022
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
32
activityPercentile
32

ranking row 2607615

17▲3Malignant Hypopharyngeal Neoplasm-436Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
396
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
4
activityPercentile
8

ranking row 2607617

17▲2Malignant Penile Neoplasm-436Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
361
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
4

ranking row 2607618

19▲7Leukemia-828Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
13584
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
88

ranking row 2607619

19▲7Malignant Central Nervous System Neoplasm-828Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10082
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
64
activityPercentile
72

ranking row 2607620

21▲9Hodgkin Lymphoma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
643
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
24
activityPercentile
36

ranking row 2607621

22▲6Malignant Gastric Neoplasm-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6436
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
48
activityPercentile
64

ranking row 2607622

22▲7Multiple Myeloma-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
6666
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
52
activityPercentile
68

ranking row 2607623

24▲7Non-Hodgkin Lymphoma-248Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11300
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
68
activityPercentile
92

ranking row 2607624

25▲7Malignant Nasopharyngeal Neoplasm-324Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
477
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
12
activityPercentile
44

ranking row 2607625

26▲10Malignant Breast Neoplasm-880Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
461
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
8
activityPercentile
96

ranking row 2607626

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 922c8783f8783cba4f334ad8